Ayman El‐Kattan

5.2k total citations
53 papers, 3.2k citations indexed

About

Ayman El‐Kattan is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ayman El‐Kattan has authored 53 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 22 papers in Pharmacology and 19 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ayman El‐Kattan's work include Drug Transport and Resistance Mechanisms (31 papers), Pharmacological Effects and Toxicity Studies (19 papers) and Pharmacogenetics and Drug Metabolism (17 papers). Ayman El‐Kattan is often cited by papers focused on Drug Transport and Resistance Mechanisms (31 papers), Pharmacological Effects and Toxicity Studies (19 papers) and Pharmacogenetics and Drug Metabolism (17 papers). Ayman El‐Kattan collaborates with scholars based in United States, United Kingdom and Japan. Ayman El‐Kattan's co-authors include Manthena V. S. Varma, C. S. Asbill, Bozena Michniak, Stefanus J. Steyn, Yurong Lai, Charles J. Rotter, Matthew D. Troutman, Katherine S. Fenner, Bo Feng and Emi Kimoto and has published in prestigious journals such as Analytical Chemistry, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Ayman El‐Kattan

53 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayman El‐Kattan United States	33	1.3k	1.0k	697	666	577	53	3.2k
Anna‐Lena Ungell Sweden	32	1.7k 1.3×	628 0.6×	863 1.2×	741 1.1×	984 1.7×	57	3.9k
Neil Parrott Switzerland	37	1.3k 1.0×	1.5k 1.4×	1.0k 1.5×	713 1.1×	1.1k 1.8×	125	4.5k
Chi‐Yuan Wu United States	15	1.5k 1.1×	971 0.9×	429 0.6×	805 1.2×	611 1.1×	19	3.0k
Constanze Hilgendorf Sweden	22	1.3k 1.0×	497 0.5×	800 1.1×	550 0.8×	361 0.6×	40	2.6k
Thierry Lavé Switzerland	35	1.1k 0.8×	1.3k 1.3×	682 1.0×	364 0.5×	239 0.4×	68	3.0k
Matthew D. Troutman United States	21	1.1k 0.8×	532 0.5×	880 1.3×	527 0.8×	177 0.3×	30	2.4k
Ismael J. Hidalgo United States	29	2.3k 1.7×	595 0.6×	1.8k 2.5×	783 1.2×	919 1.6×	70	5.6k
Teruko Imai Japan	30	872 0.7×	618 0.6×	1.2k 1.7×	190 0.3×	989 1.7×	147	4.4k
Richard Weaver United Kingdom	36	1.2k 0.9×	1.7k 1.6×	1.2k 1.7×	375 0.6×	132 0.2×	86	3.9k
Manthena V. S. Varma United States	44	3.1k 2.4×	2.1k 2.0×	1.0k 1.5×	1.5k 2.2×	830 1.4×	127	5.7k

Countries citing papers authored by Ayman El‐Kattan

Since Specialization

Citations

This map shows the geographic impact of Ayman El‐Kattan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman El‐Kattan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman El‐Kattan more than expected).

Fields of papers citing papers by Ayman El‐Kattan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman El‐Kattan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman El‐Kattan. The network helps show where Ayman El‐Kattan may publish in the future.

Co-authorship network of co-authors of Ayman El‐Kattan

This figure shows the co-authorship network connecting the top 25 collaborators of Ayman El‐Kattan. A scholar is included among the top collaborators of Ayman El‐Kattan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman El‐Kattan. Ayman El‐Kattan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Oya, Nereida Jiménez de, William P. Esler, Kim Huard, et al.. (2019). Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models. Emerging Microbes & Infections. 8(1). 624–636. 36 indexed citations

2.

Li, Rui, Mark Niosi, Nathaniel Johnson, et al.. (2018). A Study on Pharmacokinetics of Bosentan with Systems Modeling, Part 1: Translating Systemic Plasma Concentration to Liver Exposure in Healthy Subjects. Drug Metabolism and Disposition. 46(4). 346–356. 18 indexed citations

3.

El‐Kattan, Ayman, Manthena V. S. Varma, Stefanus J. Steyn, et al.. (2016). Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: Application of the Extended Clearance Classification System. Pharmaceutical Research. 33(12). 3021–3030. 34 indexed citations

4.

Varma, Manthena V. S., Stefanus J. Steyn, Charlotte Allerton, & Ayman El‐Kattan. (2015). Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Pharmaceutical Research. 32(12). 3785–3802. 223 indexed citations

5.

Leggio, Lorenzo, et al.. (2015). Development and validation of an UPLC-MS/MS assay for quantitative analysis of the ghrelin receptor inverse agonist PF-5190457 in human or rat plasma and rat brain. Analytical and Bioanalytical Chemistry. 407(19). 5603–5613. 4 indexed citations

6.

Lü, Ying, Manthena V. S. Varma, Charles J. Rotter, et al.. (2013). Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs. Journal of Controlled Release. 169(1-2). 150–161. 52 indexed citations

7.

Varma, Manthena V. S., Jian Lin, Yi‐An Bi, et al.. (2013). Quantitative Prediction of Repaglinide-Rifampicin Complex Drug Interactions Using Dynamic and Static Mechanistic Models: Delineating Differential CYP3A4 Induction and OATP1B1 Inhibition Potential of Rifampicin. Drug Metabolism and Disposition. 41(5). 966–974. 47 indexed citations

8.

Jones, Hannah M., Hugh A. Barton, Yurong Lai, et al.. (2012). Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data. Drug Metabolism and Disposition. 40(5). 1007–1017. 201 indexed citations

9.

Lai, Yurong, Manthena V. S. Varma, Bo Feng, et al.. (2012). Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development. Expert Opinion on Drug Metabolism & Toxicology. 8(6). 723–743. 45 indexed citations

10.

Kimoto, Emi, Robert L. Walsky, Hui Zhang, et al.. (2011). Differential Modulation of Cytochrome P450 Activity and the Effect of 1-Aminobenzotriazole on Hepatic Transport in Sandwich-Cultured Human Hepatocytes. Drug Metabolism and Disposition. 40(2). 407–411. 35 indexed citations

11.

Lotarski, Susan M., Sean D. Donevan, Ayman El‐Kattan, et al.. (2011). Anxiolytic-Like Activity of Pregabalin in the Vogel Conflict Test in α2δ-1 (R217A) and α2δ-2 (R279A) Mouse Mutants. Journal of Pharmacology and Experimental Therapeutics. 338(2). 615–621. 45 indexed citations

12.

Varma, Manthena V. S., Charles J. Rotter, Kevin M. Whalen, et al.. (2011). pH-Sensitive Interaction of HMG-CoA Reductase Inhibitors (Statins) with Organic Anion Transporting Polypeptide 2B1. Molecular Pharmaceutics. 8(4). 1303–1313. 99 indexed citations

13.

El‐Kattan, Ayman, et al.. (2008). The Use of 1-Aminobenzotriazole in Differentiating the Role of CYPMediated First Pass Metabolism and Absorption in Limiting Drug Oral Bioavailability: A Case Study. Drug Metabolism Letters. 2(2). 120–124. 13 indexed citations

14.

Wustrow, David J., Thomas R. Belliotti, Thomas Capiris, et al.. (2008). Oxadiazolone bioisosteres of pregabalin and gabapentin. Bioorganic & Medicinal Chemistry Letters. 19(1). 247–250. 11 indexed citations

15.

Ji, Chengjie, Wenlin Li, Ayman El‐Kattan, et al.. (2008). Diethylation Labeling Combined with UPLC/MS/MS for Simultaneous Determination of a Panel of Monoamine Neurotransmitters in Rat Prefrontal Cortex Microdialysates. Analytical Chemistry. 80(23). 9195–9203. 77 indexed citations

16.

Hurst, Susan, Cho‐Ming Loi, Joanne Brodfuehrer, & Ayman El‐Kattan. (2007). Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opinion on Drug Metabolism & Toxicology. 3(4). 469–489. 74 indexed citations

17.

Hurst, Susan, Cho‐Ming Loi, Joanne Brodfuehrer, & Ayman El‐Kattan. (2007). Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opinion on Drug Metabolism & Toxicology. 3(4). 469–489. 81 indexed citations

18.

Miller, Raymond, Wayne Ewy, Brian Corrigan, et al.. (2005). How Modeling and Simulation Have Enhanced Decision Making in New Drug Development. Journal of Pharmacokinetics and Pharmacodynamics. 32(2). 185–197. 99 indexed citations

19.

El‐Kattan, Ayman, et al.. (2001). Evaluation of derivatives of 3-(2-oxo-1-pyrrolidine) hexahydro-1H-azepine-2-one as dermal penetration enhancers: side chain length variation and molecular modeling. Journal of Controlled Release. 73(2-3). 183–196. 16 indexed citations

20.

Asbill, C. S., et al.. (2000). Evaluation of a Human Bio-Engineered Skin Equivalent for Drug Permeation Studies. Pharmaceutical Research. 17(9). 1092–1097. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact